Surgical Drainage Devices Market – Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Active, Passive), By Application (Thoracic & Cardiovascular Surgeries, Neurosurgical Procedures, Abdominal Surgery, Orthopedics, Others), By End-use (Hospitals, Ambulatory surgical centers, Clinics), By Region & Competition, 2021-2031F

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 2.69 Billion
CAGR (2026-2031)	6.43%
Fastest Growing Segment	Hospitals
Largest Market	North America
Market Size (2031)	USD 3.91 Billion

Market Overview

The Global Surgical Drainage Devices Market is projected to grow from USD 2.69 Billion in 2025 to USD 3.91 Billion by 2031 at a 6.43% CAGR. Surgical drainage devices are medical instruments designed to remove unwanted fluid, such such as blood, pus, or air, from a surgical site or body cavity, thereby preventing accumulation and promoting effective wound healing. The market for these devices is primarily driven by an increasing global volume of surgical procedures, fueled by an aging population and a rising prevalence of chronic diseases requiring operative interventions. According to the American College of Surgeons, General Surgery residency positions increased to 1,787 slots in 2025, reflecting a continuous rise in surgical activity. Growing awareness of postoperative complications and the demand for advanced wound management solutions further support market expansion.

A significant challenge impeding market growth is the inherent risk of surgical site infections associated with the use of drainage devices, as these can provide a conduit for bacterial entry into the body.

Key Market Drivers

Rising Procedure Volume and Healthcare Access
The increasing volume of surgical procedures globally significantly drives the surgical drainage devices market. This rise is attributed to broader access to healthcare, an expanding range of treatable conditions, and the growing adoption of both traditional and advanced surgical techniques. For instance, HCA Healthcare, a major hospital system, anticipates its surgical volumes will grow between 2% and 3% across 2026, indicating a steady demand for post-operative management solutions like drainage devices. As more patients undergo diverse operations, the necessity for effective fluid removal to prevent complications and accelerate recovery naturally escalates, directly boosting the demand for these instruments across various surgical specialties.

Technological Advancements in Drain Design and Materials
Concurrently, technological advancements in surgical drain design and materials are fostering market expansion. Innovations focus on enhancing device efficacy, minimizing infection risks, and improving patient comfort, which encourages broader adoption. Manufacturers are developing solutions such as closed-system drains and advanced materials that resist bacterial colonization. For example, BD launched its Surgiphor™ Surgical Wound Irrigation System in Europe during the first quarter of fiscal year 2026, expanding options for enhanced wound care. These innovations align with growing emphasis on enhanced recovery protocols and contribute to the market's trajectory, within a broader medical device landscape where 4,005 premarket approvals and 510(k) clearances were granted for devices in 2025.

Download Free Sample Report

Key Market Challenges

The inherent risk of surgical site infections (SSIs) associated with the use of drainage devices presents a significant challenge to the growth of the Global Surgical Drainage Devices Market. These devices can inadvertently act as conduits for bacterial entry into the body, leading to postoperative complications. The occurrence of SSIs results in increased healthcare costs, prolonged patient hospitalization, potential needs for reoperations, and overall diminished patient outcomes. Such adverse clinical events consequently foster clinician reluctance to utilize drainage devices when not absolutely necessary, promoting a cautious approach and a preference for alternative postoperative management strategies.

The substantial financial burden that surgical site infections impose on healthcare systems directly impacts the market by influencing purchasing patterns and adoption rates. For example, according to the American Hospital Association, total hospital expenses grew by 7.5% in 2025, with a considerable part of this increase attributed to managing complex complications such as infections that necessitate extended care and additional resources. These rising expenditures, coupled with an intensified focus on patient safety and stringent infection prevention protocols, compel healthcare facilities to meticulously evaluate the benefits versus the inherent risks of all medical instruments, including surgical drainage devices. This direct financial and clinical repercussion restricts broader market expansion and limits the widespread adoption of these devices.

Key Market Trends

The growing adoption of minimally invasive surgical procedures significantly influences the global surgical drainage devices market. As surgical techniques evolve towards smaller incisions and reduced trauma, the demand for specialized drainage solutions designed for precision and minimal invasiveness increases. These procedures, including robotic-assisted surgeries, typically lead to faster patient recovery and shorter hospital stays, requiring drainage devices that can align with these outcomes. For instance, more than 3.1 million da Vinci procedures, a prominent form of robotic-assisted minimally invasive surgery, were performed globally in 2025, demonstrating the expanding preference for less invasive interventions. This trend necessitates the development of smaller, more flexible, and highly biocompatible drainage systems that complement the reduced surgical footprint.

Concurrently, a heightened focus on infection control and the reduction of surgical site infections remains a pivotal trend impacting the market. Healthcare providers are intensely focused on mitigating postoperative complications, with surgical drainage devices playing a crucial role in preventing fluid accumulation that could foster bacterial growth. This emphasis drives the development and adoption of advanced drainage systems incorporating features like closed circuits, antimicrobial coatings, and precise fluid management capabilities. According to a report released by the American Hospital Association in December 2025, hospitals’ central line-associated bloodstream infections and catheter-associated urinary tract infections in the second quarter of 2025 were at lower rates than the fourth quarter of 2019. This ongoing commitment to infection prevention compels manufacturers to innovate, focusing on device designs that actively minimize infection risks and enhance patient safety.

Segmental Insights

The Hospitals segment is identified as the fastest-growing within the Global Surgical Drainage Devices Market. This growth is primarily attributed to the substantial volume of surgical procedures regularly performed in these facilities, ranging from general interventions to complex cardio-thoracic and orthopedic surgeries. Hospitals maintain advanced medical infrastructure and employ skilled professionals, which ensures optimal post-operative care and the effective management of surgical wounds. Furthermore, a strong emphasis on patient safety, coupled with adherence to stringent regulatory compliance, drives increased investment in standardized drainage protocols and modern devices. This commitment to enhanced patient outcomes and efficient recovery processes underpins the segment's rapid expansion.

Regional Insights

North America stands as the leading region in the Global Surgical Drainage Devices Market, primarily attributed to its highly advanced healthcare infrastructure and substantial healthcare expenditure. The region benefits from a high volume of surgical procedures, supported by favorable reimbursement policies and a significant demand for advanced surgical techniques. Furthermore, the increasing prevalence of chronic diseases and a growing aging population in North America necessitate more surgical interventions, thereby boosting the adoption of surgical drainage devices. This dominance is also reinforced by intense research and development investments and the strong presence of key market players.

Recent Developments

• In April 2026, BioStem Technologies completed the acquisition of BioTissue Holdings' surgical and wound care business. This strategic move is expected to expand BioStem's presence within major group purchasing organization networks, strengthening its position in hospital settings. The acquisition represents a significant company collaboration aimed at enhancing BioStem's offerings in the surgical and wound care market. The integration of BioTissue Holdings' portfolio is poised to provide a broader range of products and solutions, including those relevant to the management of surgical wounds and post-operative fluid, aligning with the needs of the global surgical drainage devices market.
• In March 2026, BD (Becton, Dickinson and Company), a prominent global medical technology company, announced it had received 510(k) clearance from the U.S. Food and Drug Administration for its Surgiphor™ 1000mL antimicrobial irrigation system. This product represents the first and only 1000 mL antimicrobial irrigation system specifically designed for powered lavage, offering a standardized, operating room-ready solution to improve surgical safety and efficacy. The Surgiphor™ 1000mL is intended to integrate with common powered lavage devices, facilitating the mechanical removal of debris and microorganisms from wounds, which complements surgical drainage procedures.
• In May 2025, Summit Products Group formally launched as a new healthcare solutions provider, announcing a strategic alliance with NovaBone Products. This collaboration aims to transform surgical and regenerative wound care through advanced technologies. Summit Products Group's emerging portfolio is developed for surgical applications, suitable for operating room and procedural environments. The partnership with NovaBone Products, a pioneer in regenerative medicine biomaterials, is anticipated to enhance access for clinicians to advanced healthcare technology systems in wound care, a sector directly linked to the effective management of postoperative fluid and drainage.
• In March 2025, Anuncia Medical, a company specializing in cerebrospinal fluid management, received a Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its ReFlow® External Ventricular Drain (EVD) system. This innovative solution is designed to manage brain swelling and elevated intracranial pressure, a critical aspect of neurocritical care. The ReFlow® EVD is distinguished by its noninvasive, manual flushing mechanism, which aims to restore and maintain cerebrospinal fluid flow, thereby potentially reducing the risk of occlusions, prolonged intensive care unit stays, and the need for additional neurosurgical procedures or costly EVD replacements.

Key Market Players

• Acelity L.P Inc.
• Teleflex Incorporated.
• Cardinal Health.
• Medtronic PLC.
• Cook Medical.
• Stryker Corporation.
• C.R. Bard.
• Ethicon, Inc.
• B. Braun Melsungen.
• Medela A G

By Product	By Application	By End-use	By Region
Active Passive	Thoracic & Cardiovascular Surgeries Neurosurgical Procedures Abdominal Surgery Orthopedics Others	Hospitals Ambulatory surgical centers Clinics	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Surgical Drainage Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Surgical Drainage Devices Market, By Product:

• Active
• Passive

• Surgical Drainage Devices Market, By Application:

• Thoracic & Cardiovascular Surgeries
• Neurosurgical Procedures
• Abdominal Surgery
• Orthopedics
• Others

• Surgical Drainage Devices Market, By End-use:

• Hospitals
• Ambulatory surgical centers
• Clinics

• Surgical Drainage Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE